Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes

Daigo, Sawaki, Lianguo, Hou, Shota, Tomida, Junqing, Sun, Hong, Zhan, Kenichi, Aizawa, Bo-Kyung, Son, Taro, Kariya, Eiki, Takimoto, Kinya, Otsu, Simon J., Conway, Ichiro, Manabe, Issei, Komuro, Scott L., Friedman, Ryozo, Nagai, Toru, Suzuki

Cardiovascular Research |

Aims: Kru ¨ppel-like factors (KLFs) are a family of transcription factors which play important roles in the heart under patho- logical and developmental conditions.We previously identified and cloned Klf6 whose homozygous mutation in mice results in embryonic lethality suggesting a role in cardiovascular development. Effects of KLF6 on pathological regulation of the heart were investigated in the present study. Methods: Mice heterozygous for Klf6 resulted in significantly diminished levels of cardiac fibrosis in response to angiotensin II and results infusion. Intriguingly, a similar phenotype was seen in cardiomyocyte-specific Klf6 knockout mice, but not in cardiac fibroblast-specific knockout mice. Microarray analysis revealed increased levels of the extracellular matrix factor, thrombospondin 4 (TSP4), in the Klf6-ablated heart. Mechanistically, KLF6 directly suppressed Tsp4 expression levels, and cardiac TSP4 regulated the activation of cardiac fibroblasts to regulate cardiac fibrosis. Conclusion: Our present studies on the cardiac function of KLF6 show a new mechanism whereby cardiomyocytes regulate cardiac fibrosis through transcriptional control of the extracellular matrix factor, TSP4, which, in turn, modulates activation of cardiac fibroblasts.